A Toxicologist is a scientific professional who specializes in studying the harmful effects of chemical, biological, and physical agents on living organisms. Their primary role is to assess the safety profile of substances, including new drug candidates, by evaluating their potential to cause adverse effects at various exposure levels. Using both in vitro assays and in vivo models, toxicologists investigate mechanisms of toxicity, dose-response relationships, and the likelihood of organ-specific or systemic damage. They identify thresholds for safe use and help determine acceptable exposure limits, ensuring that compounds meet stringent health and safety standards before progressing to clinical studies or commercial use.
Toxicologists collaborate with researchers, regulatory authorities, and product development teams to guide risk assessment and safety decision-making. Their expertise is critical throughout the development pipeline, from early discovery through regulatory submission. They generate comprehensive toxicology reports, interpret data trends, and recommend further testing when needed. This role also requires staying current with evolving regulatory guidelines from agencies like the FDA, EPA, or EMA. Modern advancements, such as computational toxicology, in silico modeling, and alternative testing methods, are reshaping how toxicity is predicted and evaluated, reducing reliance on animal testing. Through their meticulous work, toxicologists help ensure that new compounds are not only effective but also safe for both human health and the environment, making them indispensable to public safety and innovation.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia